Tag: Health Costs
Tonsillectomy Both Clinically Effective and Cost-Effective
Findings seen for adult patients with recurrent acute tonsillitis
Gene Therapy Not Cost-Effective for Sickle Cell by Conventional Measures
The inequality aversion parameter would need to be 0.90 for gene therapy to be preferred per distributional cost-effectiveness analysis standards
8.2 Percent of Adults Do Not Take Meds as Prescribed Due to Cost
Likelihood of not taking medication as prescribed due to cost increased for women versus men and for those with disabilities
Screening Adults for CKD Could Be Cost-Effective
One-time CKD screening at age 55 years had incremental cost-effectiveness ratio of $86,300 per QALY gained; other options were also cost-effective
Couples Age 55 or Older Can Soon Contribute $10,000 a Year to Health Savings...
The majority of Americans do not take advantage of this opportunity to save for future medical expenses
Postpartum Women Face High Burden of Medical Debt
Burden even higher among postpartum women who are poorer and those with common chronic diseases
Medicare Spending Would Increase $2.0 to $5.1 Billion With Lecanemab
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
One in Five Seniors Report Cost-Related Medication Nonadherence
Most respondents indicated a desire for use of a real-time benefit tool, with concern reported regarding inaccurate prices
Colchicine Price Increase Tied to Poorer Gout Control Over a Decade
Simultaneously, sustained decrease in colchicine use, increased use of other medications for gout, and greater health care utilization seen
Other Countries Rate Half of Top-Selling Drugs in Medicare as Low Added Benefit
These low added therapeutic-rating drugs accounted for $19.3 billion or one-third of Medicare annual net spending in 2020